Life Sciences · GEO Corporate Assessment

The crisis you thought was closed? AI tells it in the present tense.

Analysis and monitoring of corporate reputation in the answers of ChatGPT, Gemini and Perplexity — where journalists, investors and stakeholders now run their first checks.

Request the free 48-hour audit

Example sample: 480 questions to five engines, one dot per answer
ChatGPTGeminiPerplexityClaudeCopilot
  • 55%Correct
  • 18%Dated facts
  • 10%Unattended sources
  • 17%Doesn't name you
ChatGPT · the circled answer in the sample, annotated with its sources

Question“Is Meridian Pharma a reliable and ethical company?”

AI answerMeridian Pharma is a mid-sized pharmaceutical company. In 2020 it was at the centre of a controversy over the price of a medicine, covered by several outlets.1 Some sources describe its communications as not very transparent.2 [No mention of the access-to-care programme, the ESG report or partnerships with patient associations.]3

  1. DatedThe 2020 pricing controversy dominates the Wikipedia article and two national articles.en.wikipedia.org · national press · 2020
  2. UnattendedThe judgement on communications comes from a patient forum.patient forum
  3. MissingThe access-to-care programme and the patient association partnerships have no citable public source.no citable source

Illustrative example with a fictitious company. In the assessment every note links to the source URL.

The GEO Corporate Assessment for pharma is the service that analyses how generative AI engines tell the story of a pharmaceutical company to journalists, analysts and stakeholders: dated controversies over prices or pharmacovigilance still in the present tense, invisible ESG and patient advocacy, and the actions to correct the narrative.

What has changed

Whoever looks you up no longer reads ten articles. They read a summary written by an AI.

“Is [Company] a reliable and ethical company?”

“What happened with [the 20XX affair]?”

“How is [Company] positioned on ESG and access to care?”

×2ChatGPT weekly users doubled in a year: from ~400 to ~800–900 million
8%click-through when an AI answer appears (vs 15% without): your version is not read
60%of searches already end without a single click: the summary is enough

Sources: OpenAI / press 2025 · Pew Research 2025 · SparkToro 2024 — US / cross-industry data, to be read as a trend.

The problem

AI forms its view from news outlets and Wikipedia. Not from your official voice.

And every journalist, analyst or candidate starts from that summary.

The sources that matter

Where the answer comes from, for this audience

Wikipedia and national press

Controversies over prices, access or pharmacovigilance remain in the present tense until the entry and the articles are updated.

Institutional sources

AIFA, EMA, the Ministry of Health: AI cites them as authorities in questions about reliability and ethics.

Patient associations and patient advocacy

Partnerships and programmes published by associations are third-party sources AI readily picks up.

ESG reports and "facts" pages

They count if in HTML with data and dates; a PDF is not extracted.

The solution

How the GEO Assessment works

1

We ask the AI engines

We put the real questions of your audience to several models (ChatGPT, Gemini, Perplexity, Claude, Copilot), by market and role.

2

We find the sources

We identify the actual articles and pages that form that perception, with verified URLs.

3

We give you the plan, and carry it out

Score, gaps and concrete actions per touchpoint. Your team executes them, or we do: content, sources, presence. Then we measure again.

What you receive: GEO Score A–F · Visual SWOT · Source map · Reputational risks · Action plan · Competitor comparison. One branded report, exportable to PDF, generated by the proprietary ReputAction platform. And with monitoring, the same snapshot repeated over time: you see how far your positioning has moved.

The method in detail →

A case, anonymised

Pharmaceutical company, 2020 controversy over the price of a medicine

"Is it a reliable and ethical company" always opened with the controversy; the access-to-care programme, the ESG report and partnerships with associations never appeared. The plan updated Wikipedia and Wikidata, published a timeline with sources, made the ESG report extractable and worked with two patient associations to publish the joint programmes. At 90 days the controversy appears in one answer in four, with its date; access to care and patient advocacy are cited by Gemini and Perplexity.

All results →

Inside the platform

The score over time, with alerts when a narrative emerges

Monthly runs and automatic alerts: you know about a review or an article entering AI answers before a journalist reads it.

Monitoring view: GEO Score trend over 12 months with an alert on a new negative narrative

ReputAction platform interface, with sample data about a fictitious company.

Frequently asked questions

GEO Corporate Assessment for Life Sciences: the essential answers

What is the GEO Corporate Assessment for Life Sciences?

The GEO Corporate Assessment for pharma is the service that analyses how generative AI engines tell the story of a pharmaceutical company to journalists, analysts and stakeholders: dated controversies over prices or pharmacovigilance still in the present tense, invisible ESG and patient advocacy, and the actions to correct the narrative.

How does the analysis work?

We ask several AI models (ChatGPT, Gemini, Perplexity, Claude, Copilot) the real questions your audience asks, identify the sources that shape the answers, with verified URLs, and deliver a GEO Score from A to F, a SWOT, reputational risks and an action plan per channel. The demo audit is ready in 48 hours.

Do you cover ESG, access to care and patient advocacy?

Yes: they are the topics AI is asked about most often regarding a pharmaceutical company, together with prices and controversies. The assessment measures how these topics are told, from which sources, and where your official voice does not reach.

How do you handle access-to-care and pricing topics?

As facts to document: programmes, numbers, dates, institutional and association sources. Never as promotion. The regulatory perimeter is part of the method.

Do you also monitor pharmacovigilance topics?

Yes, as narratives: if a recall or a warning enters the answers, the alert flags it and the plan shows how to document the status of the case.

Who carries out the actions in the plan?

Your team, or us: every action in the report is operational (updating sources, making pages and listings readable by AI, looking after reviews and Wikipedia) and we can carry it out directly, or work alongside whoever already runs your channels.

How do I measure results (ROI)?

Through monitoring: periodic runs of the same questions on the same AI engines, GEO Score over time and a before/after comparison for each intervention. You see how far your positioning has moved against the investment, and an alert warns you if a negative narrative emerges.

How do we start, and what does it cost?

You start with a free demo audit, presented on a call within 48 hours: real AI answers about your brand and an indicative GEO Score. The full GEO Assessment starts from €5,000 for one audience and one country, with the baseline actions carried out by us and the 90-day re-analysis; the GEO Program, for serial content, PR, communities and monitoring, is quoted on the plan. Details are on the Pricing page.

The same assessment, for your industry

Not in life sciences? The same assessment exists in a standard version, for every industry.

Cross-industry version →

The next step

Start with the free 48-hour audit; then the GEO Assessment, from €5,000, with the baseline actions carried out by us and the 90-day re-analysis; the GEO Program for everything else.

Pricing and what is included →

Free audit in 48 hours

Want to see what AI says about you? We show you in 48 hours.

A free demo audit, no commitment: real AI answers about your brand and an indicative GEO Score, presented on a call.

No newsletter: we only contact you to reply.